Saturday 17 October 2026
Export AMS’s income statement to Excel — free account
American Shared Hospital Services
AMS Healthcare Medical Care Facilities
American Shared Hospital Services' revenue for fiscal 2025 (year ended December 2025) was $28.1 million, down 0.91% from fiscal 2024. In the quarter to June 2026, revenue grew 19.2%, EPS fell 75.0%, free cash flow grew 195.8% and total debt fell 32.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years; insiders bought in the last twelve months.
1.28
0.02
+1.59%
Follow AMS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.36 | 0.34 | 0.50 | 0.63 | |
P/FCF ratio |
3.07 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
4.86 | 4.54 | (19.83) | 11.11 | |
P/B ratio |
0.42 | 0.37 | 0.50 | 0.65 | |
Price to Tangible BV |
0.44 | 0.38 | 0.53 | 0.68 | |
EV/Sales |
0.95 | 1.03 | 1.29 | 1.43 | |
EV/EBITDA |
9.00 | 7.67 | 9.45 | 10.86 | |
EV/Operating CF |
5.41 | 10.93 | 11.68 | 10.31 | |
EV/FCF |
8.19 | (32.75) | (7.97) | (4.24) | |
Quick Ratio |
0.71 | 0.71 | 0.68 | 0.72 | |
Current Ratio |
0.77 | 0.77 | 0.76 | 0.80 | |
Net Debt/EBITDA |
12.61 | 16.77 | 55.21 | 15.38 | |
Debt/Assets |
30.89% | 30.78% | 31.17% | 48.32% | |
Debt/Equity |
0.63 | 0.63 | 0.62 | 1.01 | |
Asset Turnover |
0.52 | 0.49 | 0.49 | 0.48 | |
Operating CF/Net income |
(4.35) | (3.51) | 1.12 | (98.29) | |
Capex/Depreciation |
(0.04) | (0.03) | 1.50 | (2.50) | |
Interest Coverage |
(2.02) | (2.06) | (3.36) | 0.12 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
24.22% | 26.96% | 25.70% | 21.45% | |
Intangible Assets out of Total Assets |
0.03 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
1.21% | 1.43% | 1.29% | 1.41% | |
Graham Net Nets |
(0.86) | (1.00) | (0.72) | (0.56) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(15.82%) | (15.17%) | (10.90%) | (12.14%) | |
Free Cash Flow Yield |
32.56% | (9.39%) | (32.49%) | (53.35%) | |
Revenue per Share |
1.23 | 1.05 | 1.17 | 1.08 | |
Operating CF per Share |
0.33 | 0.32 | (0.11) | 0.25 | |
Capex per Share |
(0.01) | (0.01) | 0.30 | (0.56) | |
Free Cash Flow per Share |
0.32 | 0.31 | 0.19 | (0.31) | |
Cash per Share |
0.98 | 0.78 | 0.56 | 0.81 | |
Shareholders Equity per Share |
3.76 | 3.97 | 4.19 | 4.31 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.76 | 3.97 | 4.19 | 4.31 | |
Free Cash Flow |
2.18 | 2.11 | 1.28 | (2.03) | |
Working Capital |
(5.06) | (5.45) | (5.72) | (5.21) | |
Capital Expenditures |
(0.06) | (0.04) | 1.98 | (3.70) | |
Net Current Asset Value |
(9.32) | (9.75) | (10.07) | (10.44) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.01 | (0.26) | 0.52 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
9.94 | 10.59 | 12.18 | 11.60 | |
Average Payables |
0.69 | 1.16 | 1.08 | 1.45 | |
Average Assets |
57.99 | 59.02 | 57.84 | 61.45 | |
Average Common Equity |
27.33 | 27.96 | 28.86 | 30.21 |
Columns are period end dates